German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Grand Pharmaceutical Group

Market Cap: €18.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Green Thumb Industries

Market Cap: €2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

UCB

Market Cap: €40.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Perrigo

Market Cap: €1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Indivior Pharmaceuticals

Market Cap: €4.5b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Prestige Consumer Healthcare

Market Cap: €2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

UCB

Market Cap: €40.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

United Laboratories International Holdings

Market Cap: €17.2b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Bavarian Nordic

Market Cap: €14.2b

Develops, manufactures, and supplies life-saving vaccines.

United Therapeutics

Market Cap: €21.5b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Trajan Group Holdings

Market Cap: €29.0m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

ANI Pharmaceuticals

Market Cap: €1.6b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

China Resources Pharmaceutical Group

Market Cap: €30.4b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Cresco Labs

Market Cap: €502.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

China Medical System Holdings

Market Cap: €28.5b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

CorMedix

Market Cap: €634.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Consun Pharmaceutical Group

Market Cap: €11.5b

Produces and sells pharmaceutical products in Mainland China.

Bavarian Nordic

Market Cap: €14.2b

Develops, manufactures, and supplies life-saving vaccines.

Vetoquinol

Market Cap: €824.0m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

High Tide

Market Cap: €284.7m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Santen Pharmaceutical

Market Cap: €616.2b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Trulieve Cannabis

Market Cap: €1.8b

Operates as a cannabis retailer in the United States.

Hikma Pharmaceuticals

Market Cap: €3.5b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Eurofins Scientific

Market Cap: €12.2b

Provides various analytical testing and laboratory services worldwide.

Otsuka Holdings

Market Cap: €6.3t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Shionogi

Market Cap: €2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Fortrea Holdings

Market Cap: €1.7b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Viatris

Market Cap: €18.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Regeneron Pharmaceuticals

Market Cap: €80.5b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Daiichi Sankyo Company

Market Cap: €5.0t

Manufactures and sells pharmaceutical products in Japan and internationally.